By Caroline Copley ZURICH (Reuters) - Novartis raised its full-year outlook on Wednesday after generic competition to its best-selling blood pressure pill was delayed, granting the Swiss drugmaker a temporary reprieve from patent losses. The Basel...
Source: http://health.yahoo.net/news/s/nm/novartis-lifts-full-year-outlook-after-competition-delay
explained here as explained here resource source
No comments:
Post a Comment
Note: only a member of this blog may post a comment.